Marker Therapeutics Inc
Research Marker Therapeutics Inc (MRKR) on Bullrun: market cap USD 24.34M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMRKR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 24.34M
- Financial periodFY2025
- RevenueUSD 3.55M
- Revenue growth-46.2%
- Net income-USD 12.16M
Valuation Snapshot
latest market cap is USD 24.34M.
About Marker Therapeutics Inc
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets.
Frequently asked questions
What is Marker Therapeutics Inc's market cap?
Marker Therapeutics Inc's market capitalization is USD 24.34M.
What does Marker Therapeutics Inc do?
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.